移植診断薬市場：製品、技術、移植、用途、エンドユーザー別-2025年～2030年の世界予測

移植診断薬市場は、2023年に45億9,000万米ドルと評価され、2024年には49億1,000万米ドルに達すると予測され、CAGR 7.55％で成長し、2030年には76億5,000万米ドルに達すると予測されています。

移植診断薬には、移植前の適合性評価、移植後のモニタリング、移植関連合併症の診断に不可欠なさまざまな検査や処置が含まれます。これらの診断は、組織、臓器、免疫の適合性を判断する上で不可欠であり、それによって移植の成功率と患者の転帰を向上させる。主な用途としては、ヒト白血球抗原（HLA）タイピング、クロスマッチング、ドナー特異的抗体の評価などがあります。主なエンドユーザーは、病院、移植センター、研究所などです。この分野の成長は、臓器不全につながる慢性疾患の有病率の増加、分子診断学の技術的進歩、政府の支援策による臓器移植件数の増加によって推進されています。しかし、市場の拡大は、診断手順に関連する高コストや、迅速な製品承認を妨げる厳しい規制要件によって抑制されています。さらに、臓器提供者の不足がこうした課題に拍車をかけています。とはいえ、自動化とデジタル化、特に次世代シーケンシング（NGS）技術とビッグデータ解析には、診断のスピードと精度を向上させる多大な機会が存在します。企業は、人工知能と機械学習の進歩を利用して、予測分析を改良し、診断をパーソナライズすることで、患者ケアと業務効率を高めることができます。こうした機会を活用するため、企業は戦略的パートナーシップと共同研究開発に注力し、低コストで高精度のソリューションを革新すべきです。需要が伸びているにもかかわらずリソースが限られている可能性がある新興国でのアクセシビリティを優先することも、有益であることが証明されるであろう。同市場は、診断精度と効率の向上に焦点を当てた着実な技術革新が特徴であり、非侵襲的検査やリアルタイム・モニタリング・ソリューションの画期的進歩の機が熟しています。規制当局と継続的に対話し、承認プロセスを合理化することで、現在の制限を緩和し、加速的成長への道を開くことができると思われます。全体として、この複雑な市場を効果的にナビゲートするには、最先端の研究、戦略的提携、規制の変化への機敏な対応を組み合わせた多面的なアプローチが必要です。

市場力学：急速に進化する移植診断薬市場の主要市場インサイトを公開

移植診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 臓器提供に対する意識の高まりと臓器移植の増加
  • 移植診断薬の研究開発への注目の高まり
  • 新興諸国における医療ツーリズムの拡大
• 市場抑制要因
  • 臓器移植手術に伴う高コスト
• 市場機会
  • 移植診断薬における技術進歩の増加
  • 臓器移植に関する規制ガイドラインの増加
• 市場の課題
  • 保険・償還政策の欠如と臓器移植の合併症

ポーターの5つの力：移植診断薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：移植診断薬市場における外部からの影響の把握

外部マクロ環境要因は、移植診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析移植診断薬市場における競合情勢の把握

移植診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス移植診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、移植診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨移植診断薬市場における成功への道筋を描く

移植診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臓器提供に対する意識の高まりと臓器移植の増加
    • 移植診断薬の研究開発への重点化
    • 新興諸国における医療ツーリズムの拡大
  • 抑制要因
    • 臓器移植手術に伴う高額な費用
  • 機会
    • 移植診断薬における技術の進歩の増加
    • 臓器移植に関する規制ガイドラインの拡大
  • 課題
    • 保険や償還制度の欠如と臓器移植の合併症
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 移植診断薬市場：提供別

• 機器
• 試薬・消耗品
• ソフトウェアとサービス

第7章 移植診断薬市場：技術別

• 分子アッセイ
• 非分子アッセイ

第8章 移植診断薬市場：移植別

• 軟部組織移植
• 固形臓器移植
• 幹細胞移植

第9章 移植診断薬市場：用途別

• 診断アプリケーション
• 調査アプリケーション

第10章 移植診断薬市場：エンドユーザー別

• 病院と移植センター
• 独立リファレンスラボ
• 調査室および学術機関

第11章 南北アメリカの移植診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋の移植診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの移植診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • クエスト・ダイアグノスティクス、米国でどこからでもアクセスできる高度な移植診断サービスを発表
  • ヴェルフェン、輸血と移植診断薬のイノベーターを約20億米ドルで買収へ
  • サーモフィッシャーは、専門的な診断ポートフォリオを獲得するために、結合サイトを26億米ドルで買収する予定です。
  • Plexision、インドで個別移植診断検査を開始
  • ユーロフィンズ・ビラコールがカンザス州レネクサに広大な研究所を開設
  • イムコアとピルチェが複数年にわたる提携を発表
  • Eurofins Scientific SE：Transplant Genomicsは、肝臓移植患者の免疫抑制を最適化するための初の、そして唯一の非侵襲的遺伝子発現診断検査Trugraf Liverの発売を発表
  • GenDx、オックスフォード・ナノポア・テクノロジーズとの契約に基づきNGS-Turboを開発へ
  • ユーロバイオサイエンティフィックがオランダの移植診断薬企業GenDxを1億3,500万ユーロで買収
  • ホロジック、ヒトサイトメガロウイルスのAptima CMV QuantアッセイのFDA承認を発表
  • イムコアが移植診断薬のイノベーションを発表
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Adaptive Biotechnologies Corporation
• altona Diagnostics GmbH
• Arquer Diagnostics Ltd.
• BAG Group
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biogenuix Medsystems Pvt. Ltd
• BioMerieux SA
• Bruker Corporation
• CareDx, Inc.
• CLONIT srl
• Diagnostica Longwood SL
• DiaSorin S.p.A.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• Genome Diagnostics B.V.
• Hologic, Inc.
• Illumina, Inc
• Immucor, Inc.
• Laboratory Corporation of America Holdings
• Luminex Corporation
• Merck KGaA
• NanoString Technologies, Inc.
• Novartis AG
• PathoNostics B.V
• QIAGEN, N.V.
• Quest Diagnostics Incorporated
• Randox Laboratories Ltd.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• TransMedics, Inc.
• Zimmer Biomet Group

LIST OF FIGURES

• FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFT TISSUE TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOLID ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 42. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 69. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 71. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 74. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 76. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 160. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 162. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 180. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 182. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 185. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 187. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Transplant Diagnostics Market was valued at USD 4.59 billion in 2023, expected to reach USD 4.91 billion in 2024, and is projected to grow at a CAGR of 7.55%, to USD 7.65 billion by 2030.

Transplant diagnostics encompass a range of tests and procedures vital for pre-transplant compatibility assessments, post-transplant monitoring, and diagnosing transplant-related complications. These diagnostics are imperative in determining tissue, organ, and immune compatibility, thereby enhancing transplant success rates and patient outcomes. Key applications include Human Leukocyte Antigen (HLA) typing, cross-matching, and assessments of donor-specific antibodies. Major end-users comprise hospitals, transplant centers, and research laboratories. Growth in this sector is propelled by the increasing prevalence of chronic diseases leading to organ failure, technological advancements in molecular diagnostics, and a rising number of organ transplantations aided by supportive government initiatives. However, market expansion is restrained by high costs associated with diagnostic procedures and stringent regulatory requirements hampering swift product approvals. Furthermore, the scarcity of organ donors adds to these challenges. Nonetheless, tremendous opportunities exist in automation and digitalization, particularly within next-generation sequencing (NGS) technologies and big data analytics to improve diagnostic speed and precision. Companies can harness advancements in artificial intelligence and machine learning to refine predictive analytics and personalize diagnoses, thus enhancing patient care and operational efficiency. To capitalize on these opportunities, businesses should focus on strategic partnerships and collaborative R&D to innovate low-cost, high-accuracy solutions. Prioritizing accessibility in emerging economies, where demand is growing yet resources may be limited, will also prove beneficial. The market is characterized by steady innovation with a focus on improving diagnostic accuracy and efficiency, making it ripe for breakthroughs in non-invasive testing and real-time monitoring solutions. Engaging in continuous dialogue with regulatory bodies to streamline approval processes could mitigate current limitations, paving the way for accelerated growth. Overall, effective navigation of this complex market necessitates a multifaceted approach combining cutting-edge research, strategic alliances, and an agile adaptation to regulatory changes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transplant Diagnostics Market

The Transplant Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing awareness for organ donation and rise in organ transplant
  • Increased focus on research & development of transplant diagnostics
  • Growing medical tourism in developing countries
• Market Restraints
  • High cost associated with organ transplant procedures
• Market Opportunities
  • Increasing technological advancements in transplant diagnostics
  • Growing regulatory guidelines for organ transplant
• Market Challenges
  • Lack of insurance and reimbursement policies and complications of organ transplant

Porter's Five Forces: A Strategic Tool for Navigating the Transplant Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transplant Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transplant Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transplant Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transplant Diagnostics Market

A detailed market share analysis in the Transplant Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transplant Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transplant Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transplant Diagnostics Market

A strategic analysis of the Transplant Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, altona Diagnostics GmbH, Arquer Diagnostics Ltd., BAG Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMerieux SA, Bruker Corporation, CareDx, Inc., CLONIT srl, Diagnostica Longwood SL, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Genome Diagnostics B.V., Hologic, Inc., Illumina, Inc, Immucor, Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Merck KGaA, NanoString Technologies, Inc., Novartis AG, PathoNostics B.V, QIAGEN, N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., TransMedics, Inc., and Zimmer Biomet Group.

Market Segmentation & Coverage

This research report categorizes the Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services.
• Based on Technology, market is studied across Molecular Assays and Non-Molecular Assays.
• Based on Transplant, market is studied across Soft Tissue Transplant, Solid Organ Transplant, and Stem Cell Transplant.
• Based on Application, market is studied across Diagnostic Applications and Research Applications.
• Based on End User, market is studied across Hospitals & Transplant Centers, Independent Reference Laboratories, and Research Laboratories & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness for organ donation and rise in organ transplant
    • 5.1.1.2. Increased focus on research & development of transplant diagnostics
    • 5.1.1.3. Growing medical tourism in developing countries
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with organ transplant procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing technological advancements in transplant diagnostics
    • 5.1.3.2. Growing regulatory guidelines for organ transplant
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of insurance and reimbursement policies and complications of organ transplant
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transplant Diagnostics Market, by Offering

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables
• 6.4. Software & Services

7. Transplant Diagnostics Market, by Technology

• 7.1. Introduction
• 7.2. Molecular Assays
• 7.3. Non-Molecular Assays

8. Transplant Diagnostics Market, by Transplant

• 8.1. Introduction
• 8.2. Soft Tissue Transplant
• 8.3. Solid Organ Transplant
• 8.4. Stem Cell Transplant

9. Transplant Diagnostics Market, by Application

• 9.1. Introduction
• 9.2. Diagnostic Applications
• 9.3. Research Applications

10. Transplant Diagnostics Market, by End User

• 10.1. Introduction
• 10.2. Hospitals & Transplant Centers
• 10.3. Independent Reference Laboratories
• 10.4. Research Laboratories & Academic Institutes

11. Americas Transplant Diagnostics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Transplant Diagnostics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Transplant Diagnostics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Quest Diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the United States
  • 14.3.2. Werfen to acquire transfusion and transplant diagnostics innovator for around USD 2 billion
  • 14.3.3. Thermo Fisher will buy the binding site for $2.6B to gain specialty diagnostics portfolio
  • 14.3.4. Plexision launches personalized transplant diagnostic testing in India
  • 14.3.5. Eurofins Viracor opens expansive laboratory in Lenexa, KS
  • 14.3.6. Immucor and Pirche announce multi-year partnership
  • 14.3.7. Eurofins Scientific SE: Transplant Genomics announces the launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimize immunosuppression in liver transplant recipients
  • 14.3.8. GenDx to develop NGS-Turbo following agreement with Oxford Nanopore Technologies
  • 14.3.9. Eurobio Scientific buys Dutch transplant diagnostics firm GenDx for €135 million
  • 14.3.10. Hologic announces FDA approval of Aptima CMV Quant Assay For Human Cytomegalovirus
  • 14.3.11. Immucor announces innovations in transplant diagnostics
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Adaptive Biotechnologies Corporation
• 3. altona Diagnostics GmbH
• 4. Arquer Diagnostics Ltd.
• 5. BAG Group
• 6. Becton, Dickinson and Company
• 7. Bio-Rad Laboratories, Inc.
• 8. Biogenuix Medsystems Pvt. Ltd
• 9. BioMerieux SA
• 10. Bruker Corporation
• 11. CareDx, Inc.
• 12. CLONIT srl
• 13. Diagnostica Longwood SL
• 14. DiaSorin S.p.A.
• 15. Eurofins Scientific SE
• 16. F. Hoffmann-La Roche Ltd.
• 17. Genome Diagnostics B.V.
• 18. Hologic, Inc.
• 19. Illumina, Inc
• 20. Immucor, Inc.
• 21. Laboratory Corporation of America Holdings
• 22. Luminex Corporation
• 23. Merck KGaA
• 24. NanoString Technologies, Inc.
• 25. Novartis AG
• 26. PathoNostics B.V
• 27. QIAGEN, N.V.
• 28. Quest Diagnostics Incorporated
• 29. Randox Laboratories Ltd.
• 30. Takara Bio Inc.
• 31. Thermo Fisher Scientific Inc.
• 32. TransMedics, Inc.
• 33. Zimmer Biomet Group